Navigation Links
Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder
Date:10/29/2010

nse_USA_ENG.pdf) and Medication Guide, (http://medguide.shirecontent.com/MEDGUIDE/PDFs/MG_Vyvanse_USA_ENG.pdf) including Warning about Potential for Abuse, and discuss with your doctor.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure and integrate new products for commercialization and/or development; government regulation of the Company's prod
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
2. Change of Name to Shire plc
3. Shires New Product Portfolio Delivers Strong Quarterly Performance
4. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
5. Shire plc: Change to Directors Details
6. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
7. Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion
8. Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL
9. Shire Announces Opening of Office in Japan
10. Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
11. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... York and London (PRWEB) June 03, 2015 ... (NCSA) recently set a new world record by ... cores on the Blue Waters supercomputer. , ... used across many industries to stimulate innovation and ... Private Sector Program and Blue Waters manufacturer Cray ...
(Date:6/3/2015)... Global Stem Cells Group and ... to conduct Romania’s first ever stem cells harvesting and ... Miami-based Stem Cell Training, Inc., Cosmetic Surgeon Morad ... Marrow Stem Cell Training Course for medical professionals in ... practicing in Bucharest and Tel Aviv, Israel, and a ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Intelligent ... issuance of US Patent No. 9,044,273, underpinning the ... the thoraco-lumbar spinal fusion implant procedure by eliminating ... with one easy-to-use disposable instrument tray. The implants, ... numerous benefits over previous technology. Intelligent Implant Systems ...
(Date:6/2/2015)... 2015 TapImmune, Inc. (OTCQB: TPIV), a clinical ... reached an agreement whereby the institutional investors will have ... provide the Company up to $4.93M in near term ... statement. Under the restructured terms and subject to certain ... which could result in a larger influx of capital ...
Breaking Biology Technology:NCSA Scales CD-adapco’s STAR-CCM+ to New World Record of 102,000 Cores on Blue Waters 2NCSA Scales CD-adapco’s STAR-CCM+ to New World Record of 102,000 Cores on Blue Waters 3Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 2Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 3Intelligent Implant Systems Announces US Patent Attained for Revolution™ Spinal System 2TapImmune Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 2TapImmune Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 3
... Eli Lilly and Company (NYSE: LLY ) today declared ... share on outstanding common stock. This,is the same dividend as ... annual dividend for 2007 to $1.70 per share. (Logo: ... 10, 2007, to shareholders of record at,the close of business ...
... Biotechnology, Inc. presented,today new results from its drug ... Disease Drug Discovery in New York. Dr. Igor,Roninson, ... the first,drug candidates that block aging cells from ... disease, including: amyloid,precursor protein (APP); BACE1 that converts ...
... Liver Meeting is the premier,meeting in the science and ... novel treatments, and the results from pilot and,multicenter studies. ... of liver disease,and the diseases strike disproportionately among certain ... numerous treatments,for both hepatitis B and C, whereas liver ...
Cached Biology Technology:Senex Biotechnology Announces Presentation of Alzheimer's Disease Drug Discovery Effort 2Senex Biotechnology Announces Presentation of Alzheimer's Disease Drug Discovery Effort 3
(Date:5/20/2015)... 2015 Research ... the addition of the  "5-year Opportunity ... Market"  report to their offering.  ,     ... analyses trends in the iris recognition ... sectors, globally. Despite hardware pricing and ...
(Date:5/19/2015)... , May 19, 2015  Technology is rapidly ... internally and in the cloud. Passwords and their management ... of OTP and standards-based specifications such as those developed ... outmoded use of passwords presents for BYOD, COPE, IoT, ... unified biometric identity protocol. In response ...
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
... July 31, 2012 - After an epic 354-million-mile trek ... at 13,000 miles per hour toward a scheduled August ... evidence of extraterrestrial life. The newest episode of the ... video series highlights Curiosity Rover,s mission, scientific instrumentation and ...
... athletes may be the best trained and physically conditioned ... to back pain. BackPainRelief.net is releasing an infographic detailing ... can be avoided. (Photo: http://photos.prnewswire.com/prnh/20120730/CG48619-INFO ... a number of injuries, and back pain is among ...
... being sick doesn,t mean making a trip to the local ... turning to the forest to provide a pharmacopeia of ... But while questions persist about whether such natural ... researcher is examining the phenomenon from a unique perspective, and ...
Cached Biology News:Backpainrelief.net Tackles Sports Injuries with Infographic 2Health care savings, naturally 2Health care savings, naturally 3